Home RSS :: Send Tips :: Advertise :: Contact ::

Archive - September 2006

Ascending Descending
Gautam | Sep 29 2006
south africa
With every country trying to make a mark in the field of biotechnology, South Africa has a different story to tell. South Africa's private sector seems to lag behind the public sector on R&D in the biotechnology sector. There are facts to prove this....
Gautam | Sep 28 2006
hay fever
In a recent development, Cytos Biotechnology has created a drug called CYT003-QbG10 which bamboozles the body into changing tactics in order to focus on tackling the larger threats rather production of allergic reactions to less harmful things....
Gautam | Sep 28 2006
lung cancer
Do you know that lung cancer kills most among other forms of cancer and just around five percent of the patients survive for more than five years? Up till now all efforts to come with a solution for this menace have failed and this disease has not seen.
Gautam | Sep 28 2006
vaccine12
A Halifax based biotech company has been successful in destroying huge cancer tumors in mice with their new vaccine technology. The company called ImmunoVaccine Technologies is soon expected to start Phase I clinical trials of its technology on human...
Gautam | Sep 27 2006
wheat1
As per a report by Robert Wisner of Iowa State University introduction of GM wheat in U.S. would hit the export trade of the country in durum and hard red spring wheat and would also affect the prices of these variety of wheat. The report further...
Gautam | Sep 27 2006
bio incubator
Realizing the needs of the biotechnology sector in Flanders, Flanders Interuniversity Institute for Biotechnology (VIB) is coming up with a new bio-incubator in the technology park in Zwijnaarde. The new bio-incubator would enable to start up new...
Gautam | Sep 26 2006
cotton
The regulatory authority for biotechnology crops in India, Genetic Engineering Approval Committee (GEAC) has stated that India has witnessed an increase in the area under plantation with GM insect protected cotton from 1.2 million hectares to 3.2...
Gautam | Sep 26 2006
aids
Scientific and financial risks are preventing a number of biotechnology and pharmaceutical companies from making huge investments with their own funds in AIDS vaccine research. Companies fear that they might not be able to recover their long term...
Gautam | Sep 26 2006
biotech64
BASF undertakes investment in new energy generation technology research activities in the areas of energy management and industrial biotechnology. In order to further its interests BASF is in the process of investing 3 million in LUCA Technologies....
Gautam | Sep 26 2006
ronald d henriksen
Jeff Swiatek got an opportunity to interview Ronald D. Henriksen, an innovator and former Lilly executive who was there when biotechnology revolution started in 1976 and when world's leading biotech engineers came together for comparing their notes at..